Sponsor:
UCLA
Code:
NCT06665971
Conditions
Eosinophilic Esophagitis (EoE)
Eligibility Criteria
Sex: All
Age: 22+
Healthy Volunteers: Not accepted
Interventions
Dupilumab 300 MG/2 ML Subcutaneous Solution [DUPIXENT]
Trial information was received from ClinicalTrials.gov and was last updated on 2026-08-27. This information was provided to ClinicalTrials.gov by University of California, San Diego on 2024-12-11.